Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huiling Xiang

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Current Oncology (Toronto, Ont.)|March 28, 2023
A Nomogram for Preoperative Prediction of the Risk of Lymph Node Metastasis in Patients with Epithelial Ovarian CancerHuiling Xiang, Fan Yang, Xiaojing Zheng, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|April 28, 2024
Early growth response protein 2 promotes partial epithelial-mesenchymal transition by phosphorylating Smad3 during renal fibrosisAnni Song, Ruiwei Yan, Wei Xiong, et al.
The Journal of International Medical Research|October 13, 2022
Correlations between serum hepatitis B core-related antigen and hepatitis B surface antigen in patients with hepatitis B cirrhosis and a hepatitis B virus-DNA-negative status: a retrospective studyBaiguo Xu, Anjing Liu, Ying Liu, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|November 18, 2015
[A randomized controlled trial on 240-week monotherapy with entecavir or adefovir in patients with chronic hepatitis B and cirrhosis]Jia Lian, Tao Han, Huiling Xiang, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|May 15, 2025
Automated whole-breast ultrasound tumor diagnosis using attention-inception networkJun Zhang, Yao-Sian Huang, You-Wei Wang, et al.
Frontiers in Immunology|March 6, 2023
Tislelizumab for cervical cancer: A retrospective study and analysis of correlative blood biomarkersXiaojing Zheng, Haifeng Gu, Xinping Cao, et al.
Scientific Reports|November 9, 2023
Identification of a bile acid and bile salt metabolism-related lncRNA signature for predicting prognosis and treatment response in hepatocellular carcinomaHao Cui, Jia Lian, Baiguo Xu, et al.
The Journal of Pathology|May 9, 2024
Multiomics sequencing and immune microenvironment characteristics define three subtypes of small cell neuroendocrine carcinoma of the cervixBaoyue Pan, Shumei Yan, Linjing Yuan, et al.
Frontiers in Immunology|January 26, 2026
The impact of metabolic dysfunction-associated steatotic liver disease on the efficacy of pegylated interferon-based therapy in patients with chronic hepatitis BJiaxin Han, Lianxin Xu, Yuqin Li, et al.
Cancer Medicine|October 9, 2024
The efficacy of first and second immunotherapy exposure in patients with recurrent or metastatic cervical cancerMingxiu Ju, Baoyue Pan, Yongwen Huang, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Current Oncology (Toronto, Ont.)|March 28, 2023
A Nomogram for Preoperative Prediction of the Risk of Lymph Node Metastasis in Patients with Epithelial Ovarian CancerHuiling Xiang, Fan Yang, Xiaojing Zheng, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|April 28, 2024
Early growth response protein 2 promotes partial epithelial-mesenchymal transition by phosphorylating Smad3 during renal fibrosisAnni Song, Ruiwei Yan, Wei Xiong, et al.
The Journal of International Medical Research|October 13, 2022
Correlations between serum hepatitis B core-related antigen and hepatitis B surface antigen in patients with hepatitis B cirrhosis and a hepatitis B virus-DNA-negative status: a retrospective studyBaiguo Xu, Anjing Liu, Ying Liu, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|November 18, 2015
[A randomized controlled trial on 240-week monotherapy with entecavir or adefovir in patients with chronic hepatitis B and cirrhosis]Jia Lian, Tao Han, Huiling Xiang, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|May 15, 2025
Automated whole-breast ultrasound tumor diagnosis using attention-inception networkJun Zhang, Yao-Sian Huang, You-Wei Wang, et al.
Frontiers in Immunology|March 6, 2023
Tislelizumab for cervical cancer: A retrospective study and analysis of correlative blood biomarkersXiaojing Zheng, Haifeng Gu, Xinping Cao, et al.
Scientific Reports|November 9, 2023
Identification of a bile acid and bile salt metabolism-related lncRNA signature for predicting prognosis and treatment response in hepatocellular carcinomaHao Cui, Jia Lian, Baiguo Xu, et al.
The Journal of Pathology|May 9, 2024
Multiomics sequencing and immune microenvironment characteristics define three subtypes of small cell neuroendocrine carcinoma of the cervixBaoyue Pan, Shumei Yan, Linjing Yuan, et al.
Frontiers in Immunology|January 26, 2026
The impact of metabolic dysfunction-associated steatotic liver disease on the efficacy of pegylated interferon-based therapy in patients with chronic hepatitis BJiaxin Han, Lianxin Xu, Yuqin Li, et al.
Cancer Medicine|October 9, 2024
The efficacy of first and second immunotherapy exposure in patients with recurrent or metastatic cervical cancerMingxiu Ju, Baoyue Pan, Yongwen Huang, et al.
Pageof 7